 |
|
New research provides hope for childhood cancer sufferers
July 23, 2007Dr Richard Lock, Head of the Leukaemia Biology Program at the Children's Cancer Institute Australia for Medical Research, Sydney, along with collaborators from the Childrens Hospital Los Angeles and University of Southern California, USA, recently published their findings in the prestigious scientific journal Blood.
ALL is the most common form of childhood cancer. Over the years, improvements in primary therapy have increased the cure rate to approximately 80 percent. However, for the 20 percent of patients who relapse, the majority will die.
"When used in combination with common drugs administered in ALL therapy, ABT-737 has the ability to enhance the combined toxicity of these drugs against the leukaemia cells with minimal effects on the normal cells of the body," said Dr Lock.
Resistance to common therapeutic drugs is associated with poor long-term outcomes in leukaemia patients. In the study, the effects of ABT-737 in combination with three common chemotherapeutic agents: L-Asparaginase, vincristine and dexamethasone, were tested on a number of ALL cell lines under conditions which were considered clinically relevant for the disease.
ABT-737, developed by Abbott Laboratories, acts by inhibiting the Bcl-2 family of proteins. These proteins are expressed in ALL and inhibit the mechanisms responsible for destroying leukaemia cells. High levels of expression of Bcl-2 is linked with chemoresistance in a variety of cancers.
"There is a critical need for new drugs with novel mechanisms of action that might improve the outcome for relapsed ALL patients," said Dr Lock.
Research Australia
Resistance to common therapeutic drugs is associated with poor long-term outcomes in leukaemia patients. In the study, the effects of ABT-737 in combination with three common chemotherapeutic agents: L-Asparaginase, vincristine and dexamethasone, were tested on a number of ALL cell lines under conditions which were considered clinically relevant for the disease.
ABT-737, developed by Abbott Laboratories, acts by inhibiting the Bcl-2 family of proteins. These proteins are expressed in ALL and inhibit the mechanisms responsible for destroying leukaemia cells. High levels of expression of Bcl-2 is linked with chemoresistance in a variety of cancers.
"There is a critical need for new drugs with novel mechanisms of action that might improve the outcome for relapsed ALL patients," said Dr Lock.
Research Australia
Leukaemia Current Events and Leukaemia News RSSNew hope for multiple sclerosis sufferers
A drug which was developed in Cambridge and initially designed to treat a form of leukaemia has also proven effective against combating the debilitating neurological disease multiple sclerosis (MS).
Getting to grips with the complexity of disease proteins
Drug molecules seldom act simply on one protein but on protein complexes and networks. A deeper understanding of these 'cooperative assemblies' should lead to better targeting of drugs.
First step towards switching off breast cancer and leukaemia
Australian scientists have identified a way to 'switch off' a molecule, a key player in the molecular processes that trigger breast cancer and certain forms of leukaemia.
Heavy birthweight babies twice as likely to develop rheumatoid arthritis
Heavy birthweight female babies are twice as likely to develop rheumatoid arthritis in adulthood as their average birthweight peers, suggests research published ahead of print in the Annals of the Rheumatic Diseases.
New analysis finds daycare attendance early in life cuts childhood leukemia risk by 30 percent
Children who attend day care or play groups have about a 30% lower risk of developing the most common type of childhood leukaemia than those who do not, according to a new analysis of studies investigating the link.
Cancer could return unless stored ovarian tissue undergoes adequate testing before re-implantation
Cancer patients who have been successfully treated for their disease face the prospect of its return if stored ovarian (or testicular) tissue is transplanted back into their bodies without adequate checks, according to researchers at two university hospitals in Israel.
Families of children with cancer support human tissue research, study finds
Families of children with cancer support research using tissue samples left over after operations, a new study has found.
New bacteria contaminate hairspray
Scientists in Japan have discovered a new species of bacteria that can live in hairspray, according to the results of a study published in the March issue of the International Journal of Systematic and Evolutionary Microbiology.
Stem cells give clues to understanding cancer and make breakthrough in childhood leukaemia
Scientists in Switzerland are uncovering new clues about how cancer cells grow - and how they can be killed - by studying stem cells, 'blank' cells that have the potential to develop into fully mature or 'differentiated' cells and other scientists in UK have made a breakthrough in understanding the cause of the most common form of childhood cancer, acute lymphoblastic leukaemia (ALL).
Overweight and obesity cause 6,000 cancers a year in UK women
The study shows that overweight and obese women in the UK are at a higher risk of developing and dying from cancer. In fact, the researchers estimate that 5% of all cancers (about 6,000 annually) are attributable to being overweight or obese.
More Leukaemia Current Events and Leukaemia News Articles
| Leukaemia Diagnosis: A Guide to the Fab Classification by Barbara J. Bain | |
| Leukaemias, Lymphomas and Allied Disorders by A.H. Goldstone, etc. | |
 | Cancer and Leukaemia: An Alternative Approach (By Appointment Only) by Jan de Vries In this volume, Jan de Vries explains what sufferers of cancer and leukaemia can do to help themselves, emphasizing the need for a positive approach to cancer and relieving the stress it causes through exercise and visualization... |
| LEUKAEMIA RESEARCH by CIBA FOUNDATION | |
| The Chronic Leukaemias: Clinics in Haematology, Vol 6 Number 1 February 1977 by D.A.G. (Editor) Galton | |
| Adult T-cell Leukaemia (Oxford Medical Publications) Advances made so far in the worldwide study of AIDS and HIV owe much to our knowledge of T-cell leukaemia, which is the first human cancer known to be caused by a retrovirus. This book records the state-of-the-art findings on ATL and related diseases, and reviews the information which has been accumalated over the past two decades. Contributions from leading experts cover haematology,... | |
| Cancer and Leukaemia in Childhood Trust Celebrity Cook Book | |
| Comparative Leukaemia Research (Bibliotheca haematologica) | |
| WELLCOME WITNESSES TO TWENTIETH CENTURY MEDICINE VOLUME 15: LEUKAEMIA: WITNESS SEMINAR TRANSCRIPT. by D. A. & E. M. Tansey (edits). Christie | |
| Comparative Leukaemia Research Comparative Leukemia Research by G. Winquist |
| © 2008 BrightSurf.com |